Clinical trial
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
NCT03947346 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 9, 2019
- Completion date
- July 15, 2025
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuroblastoma survivors